IPO

Silexion Therapeutics Receives $6 Price Target and Buy Rating From Litchfield Hills Research (NASDAQ: SLXN)

WSW, NY, 15th December 2025, FinanceWire … Read More

InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR)

WSW, NY, 12th December 2025, FinanceWire … Read More

Inspira Technologies May be Perfectly Positioned as Flu Cases Increase and Respiratory Complexity Grows (NASDAQ: IINN)

WSW, NY, 11th December 2025, FinanceWire … Read More

Alpha Tau Medical Just Treated Its First Brain Tumor Patient – and It Could Mark an Inflection Point for the Company (NASDAQ: DRTS)

WSW, NY, 10th December 2025, FinanceWire … Read More

PolyPid Clears a Key FDA Milestone, Reducing Regulatory Risk Ahead of Its Planned NDA Filing (NASDAQ: PYPD)

WSW, NY, 5th December 2025, FinanceWire … Read More

DarioHealth is Gaining Strong Momentum as GLP-1 Costs Reshape Employer Health Strategy (NASDAQ: DRIO)

WSW, NY, 5th December 2025, FinanceWire … Read More

Duke Robotics is Positioning Its Technology to Meet America’s Emerging Grid Security Demands (OTCQB: DUKR)

WSW, NY, 4th December 2025, FinanceWire … Read More

BiomX Is Targeting the Infection Threat Returning to Modern War – And the Military Is Paying Attention (NYSE: PHGE)

WSW, NY, 4th December 2025, FinanceWire … Read More

TrustFinance Announces Winners of the Performance Awards 2025, Recognizing Global Leaders in Finance

Singapore, Singapore, 3rd December 2025, FinanceWire … Read More

Silexion Therapeutics Advances Toward a Late-Stage Phase 2/3 Trial in Pancreatic Cancer With Strong Regulatory Momentum (NASDAQ: SLXN)

WSW, NY, 2nd December 2025, FinanceWire … Read More